default author photo

Yi Zhang

Government of the People's Republic of China - Daping Hospital

Chongqing

China

The 452nd Hospital of PLA

Sichuan

China

SCHOLARLY PAPERS

1

DOWNLOADS

47

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Advanced Non-Small-Cell Lung Cancer Patients with Low Tumor Mutation Burden Might Derive Benefit from Immune Checkpoint Inhibitors

Number of pages: 24 Posted: 28 Sep 2018
Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - Zhongshan Hospital, Government of the People's Republic of China - Daping Hospital, Shanghai Applied Protein Technology Co.Ltd (APTBIO), Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Lung Tumor Clinical Medical Center, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital and Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine
Downloads 47 (1,097,529)

Abstract:

Loading...

non-small cell lung cancer; tumor mutation burden; immune checkpoint inhibitor